Next Article in Journal
Effect of Sterilization Methods on Chemical and Physical-Mechanical Properties of Cotton Compresses
Previous Article in Journal
A Close View of the Production of Bioactive Fungal Metabolites Mediated by Chromatin Modifiers
Previous Article in Special Issue
Targeting B7-H3—A Novel Strategy for the Design of Anticancer Agents for Extracranial Pediatric Solid Tumors Treatment
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Review

Recent Development of Fluoroquinolone Derivatives as Anticancer Agents

by
Justyna Nowakowska
1,*,
Dominika Radomska
2,
Robert Czarnomysy
2 and
Krzysztof Marciniec
1,*
1
Department of Organic Chemistry, Medical University of Silesia, Jagiellonska 4, 41-200 Sosnowiec, Poland
2
Department of Synthesis and Technology of Drugs, Medical University of Bialystok, Kilinskiego 1, 15-089 Bialystok, Poland
*
Authors to whom correspondence should be addressed.
Molecules 2024, 29(15), 3538; https://doi.org/10.3390/molecules29153538 (registering DOI)
Submission received: 20 June 2024 / Revised: 17 July 2024 / Accepted: 25 July 2024 / Published: 27 July 2024
(This article belongs to the Special Issue Novel Design and Synthesis of Anticancer Agents (Second Edition))

Abstract

Cancer is the second leading cause of death in the world following cardiovascular disease. Its treatment, including radiation therapy and surgical removal of the tumour, is based on pharmacotherapy, which prompts a constant search for new and more effective drugs. There are high costs associated with designing, synthesising, and marketing new substances. Drug repositioning is an attractive solution. Fluoroquinolones make up a group of synthetic antibiotics with a broad spectrum of activity in bacterial diseases. Moreover, those compounds are of particular interest to researchers as a result of reports of their antiproliferative effects on the cells of the most lethal cancers. This article presents the current progress in the development of new fluoroquinolone derivatives with potential anticancer and cytotoxic activity, as well as structure–activity relationships, along with possible directions for further development.
Keywords: fluoroquinolones; anticancer; cytotoxic activity; metal ion complexes fluoroquinolones; anticancer; cytotoxic activity; metal ion complexes

Share and Cite

MDPI and ACS Style

Nowakowska, J.; Radomska, D.; Czarnomysy, R.; Marciniec, K. Recent Development of Fluoroquinolone Derivatives as Anticancer Agents. Molecules 2024, 29, 3538. https://doi.org/10.3390/molecules29153538

AMA Style

Nowakowska J, Radomska D, Czarnomysy R, Marciniec K. Recent Development of Fluoroquinolone Derivatives as Anticancer Agents. Molecules. 2024; 29(15):3538. https://doi.org/10.3390/molecules29153538

Chicago/Turabian Style

Nowakowska, Justyna, Dominika Radomska, Robert Czarnomysy, and Krzysztof Marciniec. 2024. "Recent Development of Fluoroquinolone Derivatives as Anticancer Agents" Molecules 29, no. 15: 3538. https://doi.org/10.3390/molecules29153538

Article Metrics

Article metric data becomes available approximately 24 hours after publication online.
Back to TopTop